Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Emma Scott

Newcastle AuthorsTitleYearFull text
Esme Hutton
Dr Emma Scott
Professor Craig Robson
A general and accessible approach to enrichment and characterisation of natural anti-Neu5Gc antibodies from human samples2025
Caroline Dalgliesh
Saad Aldalaqan
Christian Atallah
Dr Andrew Best
Dr Emma Scott
et al.		An ultra-conserved poison exon in the Tra2b gene encoding a splicing activator is essential for male fertility and meiotic cell division2025
Kayla Bastian
Maggie Orozco Moreno
Huw Thomas
Dr Kirsty Hodgson
Laura Wilson
et al.		FUT8 Is a Critical Driver of Prostate Tumour Growth and Can Be Targeted Using Fucosylation Inhibitors2025
Dr Emma Scott
Professor Craig Robson
A systematic review reveals conflicting evidence for the prevalence of antibodies against the sialic acid ‘xenoautoantigen’ Neu5Gc in humans and the need for a standardised approach to quantification2024
Dr Kirsty Hodgson
Maggie Orozco Moreno
Emily Archer Goode
Dr Rebecca Garnham
Karen Livermore
et al.		Sialic acid blockade inhibits the metastatic spread of prostate cancer to bone2024
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.		ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2024
Zainab Alebady
Dr Mahsa Azizyan
Dr Sirintra Nakjang
Dr Emma Lishman-Walker
Jesslyn Choo
et al.		CDC20 is regulated by the histone methyltransferase, KMT5A, in castration resistant prostate cancer2023
Dr Adriana Buskin
Dr Emma Scott
Ryan Nelson
Dr Luke Gaughan
Professor Craig Robson
et al.		Engineering prostate cancer in vitro: what does it take?2023
Rahul Advani
Dr Sara Luzzi
Dr Emma Scott
Caroline Dalgliesh
Dr Jennifer Munkley
et al.		Epithelial specific splicing regulator proteins as emerging oncogenes in aggressive prostate cancer2023
Rebecca Garnham
Dr Daniel Geh
Ryan Nelson
Erik Ramon Gil
Laura Wilson
et al.		ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer2023
Dr Emma Scott
Emily Archer Goode
Rebecca Garnham
Dr Kirsty Hodgson
Maggie Orozco Moreno
et al.		ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression2023
Dr Kirsty Hodgson
Maggie Orozco Moreno
Dr Emma Scott
Rebecca Garnham
Karen Livermore
et al.		The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer2023
Dr Emma Scott
Dr Kirsty Hodgson
Kat Cheung
Edward Yo
Laura Wilson
et al.		Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth2023
Dr Emma Scott
Rebecca Garnham
Adam Duxfield
Professor David Elliott
Dr Jennifer Munkley
Pro-Survival Factor EDEM3 Confers Therapy Resistance in Prostate Cancer2022
Kayla Bastian
Dr Emma Scott
Professor David Elliott
Dr Jennifer Munkley
Fut8 alpha-(1,6)-fucosyltransferase in cancer2021
12